VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Age 60 years or older                              │ Age 60 years or older                              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Fluent in English                                  │ Fluent in English                                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current or past diagnoses of other Axis I          │ Current or past diagnoses of other Axis I          │     100 │
│ psychiatric disorders, except for generalized      │ psychiatric disorders, except for generalized      │         │
│ anxiety disorder (GAD) symptoms occurring during a │ anxiety disorder (GAD) symptoms occurring during a │         │
│ depressive episode                                 │ depressive episode                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of alcohol or drug dependence or abuse in  │ History of alcohol or drug dependence or abuse in  │     100 │
│ the last three years                               │ the last three years                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Presence of acute suicidality                      │ Presence of acute suicidality                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current or past psychosis                          │ Current or past psychosis                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Primary neurological disorder, including but not   │ Primary neurological disorder, including but not   │     100 │
│ limited to dementia, stroke, brain tumors,         │ limited to dementia, stroke, brain tumors,         │         │
│ epilepsy, Parkinson's disease, or demyelinating    │ epilepsy, Parkinson's disease, or demyelinating    │         │
│ diseases                                           │ diseases                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ MRI contraindications                              │ MRI contraindications                              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any physical or intellectual disability adversely  │ Any physical or intellectual disability adversely  │     100 │
│ affecting ability to complete assessments          │ affecting ability to complete assessments          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Electroconvulsive therapy in last 6 months         │ Electroconvulsive therapy in last 6 months         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of antidepressant medications or other         │ Use of antidepressant medications or other         │     100 │
│ psychotropic medications in the last 4 weeks (or   │ psychotropic medications in the last 4 weeks (or   │         │
│ the last 6 weeks for fluoxetine). Occasional use   │ the last 6 weeks for fluoxetine). Occasional use   │         │
│ of benzodiazepines or non-benzodiazepine sedatives │ of benzodiazepines or non-benzodiazepine sedatives │         │
│ (such as zolpidem, eszopiclone, or zaleplon)       │ (such as zolpidem, eszopiclone, or zaleplon)       │         │
│ during this period is allowable                    │ during this period is allowable                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A failed therapeutic trial of escitalopram in the  │ A failed therapeutic trial of escitalopram in the  │     100 │
│ current depressive episode (defined as at least 6  │ current depressive episode (defined as at least 6  │         │
│ weeks of treatment at a daily dose of 10mg or      │ weeks of treatment at a daily dose of 10mg or      │         │
│ higher)                                            │ higher)                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known allergy or hypersensitivity to escitalopram  │ Known allergy or hypersensitivity to escitalopram  │     100 │
│ or bupropion                                       │ or bupropion                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current or planned psychotherapy                   │ Current or planned psychotherapy                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current diagnosis of major depressive disorder     │ Current diagnosis of major depressive disorder     │      87 │
│ (DSM-IV-TR), single episode, recurrent or chronic, │ (DSM-IV-TR), single episode, recurrent or chronic, │         │
│ without psychotic features, as detected by Mini-   │ without psychotic features, as detected by MINI    │         │
│ International Neuropsychiatric Inventory (MINI)    │ and clinical exam                                  │         │
│ and clinical exam                                  │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Minimum MADRS score ≥ 15                           │ Minimum MADRS score = 15                           │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Mini-Mental State Exam ≥ 24                        │ Mini-Mental State Exam = 24                        │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Acute grief (\< 1 month)                           │ Acute grief (< 1 month)                            │      98 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 60 Years                 │ Minimum MADRS score = 15                           │      42 │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of developmental disorder or Intelligence │ History of developmental disorder or IQ score < 70 │      83 │
│ Quotient score \< 70                              │                                                    │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ History of developmental disorder or Intelligence │ History of developmental disorder or IQ score < 70 │      83 │
│ Quotient score \< 70                              │                                                    │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 94.52380952380952
OverAll Ratio: 95.26190476190476
